Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 14, 2017 09:45 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Announces Term Sheet with EOC Pharma for Development of Telatinib

BATON ROUGE, LA--(Marketwired - March 14, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
March 13, 2017 08:00 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network

BATON ROUGE, LA--(Marketwired - March 13, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
February 02, 2017 09:59 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Announces Cancer Vaccine Poster Presentation at the 2017 American Association for Cancer Research Meeting

BATON ROUGE, LA--(Marketwired - February 02, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
January 26, 2017 15:47 ET | Source: OncBioMune Pharmaceuticals, Inc.

Latest Clinical Data from OncBioMune Supports Safety and Therapeutic Profile of ProscaVax for Prostate Cancer for Upcoming Phase 2 Clinical Trials

BATON ROUGE, LA--(Marketwired - January 26, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
January 18, 2017 14:50 ET | Source: OncBioMune Pharmaceuticals, Inc.

Departments of Urology and Oncology Approve Protocol for OncBioMune's Phase 2/3 Trial of ProscaVax for Prostate Cancer in Mexico

BATON ROUGE, LA--(Marketwired - January 18, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
January 10, 2017 08:00 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Submitting Clinical Trial of World's First Early-Stage Prostate Cancer Vaccine to The Cancer Therapy Evaluation Program (CTEP) at the National Cancer Institute

BATON ROUGE, LA--(Marketwired - January 10, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
December 28, 2016 09:36 ET | Source: OncBioMune Pharmaceuticals, Inc.

Patients Pre-Screened for OncBioMune Pharmaceuticals Phase 2/3 Trial of ProscaVax for Prostate Cancer

BATON ROUGE, LA--(Marketwired - December 28, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
December 12, 2016 09:28 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Awarded Patent in Europe Protecting Novel Cancer Vaccine Technology

BATON ROUGE, LA--(Marketwired - December 12, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
December 08, 2016 09:00 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune and the Clinical Trial Investigators Have Agreed Upon the Protocol for Their Phase 2 Trial of Novel Vaccine for Early Stage Prostate Cancer

BATON ROUGE, LA--(Marketwired - December 08, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune"), a clinical stage biopharmaceutical company engaged in the development of novel...
December 07, 2016 08:30 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Provides Update on Acquisition of Vitel Laboratorios

BATON ROUGE, LA--(Marketwired - December 07, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune"), a clinical stage biopharmaceutical company engaged in the development of novel...